Marko Tvrdic is cofounder and COO at Exin Therapeutics, a company focused on therapeutic development. He holds an MSc and PhD from Oxford and has research experience across molecular biology, neuroscience disciplines including retinal disorders, circadian biology, and neurodevelopment, with prior exposure to venture capital.
Intro paths
YC
Marko went through Y Combinator (Winter 2025) — any YC alum in your network can reach them through the YC community.
→
In turn, Marko can intro founders to Exin Therapeutics's investors below.
Exin Therapeutics's investors · 1
Co-founders
Gabriel Ocana Santero· Founder